Introduction
Quinolones and fluoroquinolones have been classified as critically important for human health by the World Health Organization (WHO, 2017) . Resistance to these compounds has become widespread in Europe, and the occurrence of resistance has increased significantly from 2012 to 2015 (ECDC, 2016) . Due to this rapid dissemination, the need for proper surveillance of antimicrobial resistance is paramount for both human and animal health alike (Queenan et al., 2016; Robinson et al., 2016) .
The Norwegian monitoring programme for antimicrobial resistance in the veterinary sector (NORM-VET) was established in 2000 as part of a national strategy plan against antimicrobial resistance. The occurrence of quinolone resistance, as defined by epidemiological cut-off values (ECOFF; EUCAST, www.eucast.org), in indicator E. coli from healthy animal species has been monitored in NORM-VET since its beginning. Culturing and isolation methods have been used to identify E. coli from the samples collected. A random E. coli from each sample has been tested for the sensitivity to a range of substances, hereafter called the traditional method, of which the quinolones nalidixic acid and enrofloxacin (until 2005) or ciprofloxacin (from 2006) have been included. In 2014, an additional selective screening method for quinolone resistant E. coli (QREC) was introduced in the NORM-VET programme (NORM/NORM- VET, 2014 VET, , 2015 VET, , 2016 . The selective method showed that QREC is present at low levels in a high proportion of the samples from some healthy animal species. The results from this screening indicated that there is a substantial difference in occurrence of QREC between animal species, with the most frequent findings being in broilers and pigs. Data from many years of sampling in different animals using the traditional method provides us with a unique opportunity to study the occurrence of QREC over time. Moreover, the data can be used to determine if the observed variation of QREC occurrence in various animal species could be detected as with the selective screening methodology. Furthermore, differences in occurrences over time can be compared to other factors such as human population density. This has previously been observed for QREC detected with the selective method in samples from red foxes (Mo et al., 2017) .
The aim of this study was to describe and compare the occurrence of QREC in different animal species in relation to population density for a better understanding of the dissemination and occurrence of QREC in animals in Norway. Additionally, we wanted to see if the same species variation identified by selective screening for QREC was identifiable in indicator E. coli.
Materials and methods

Data sources and management
Data from the NORM-VET programme from 2006 to 2016 (NORM/ NORM- VET, 2006 VET, , 2007 VET, , 2008 VET, , 2009 VET, , 2010 VET, , 2011 VET, , 2012 VET, , 2013 VET, , 2014 VET, , 2015 VET, , 2016 , including information about species, sampled material, date of sampling, and production site or sample site (municipality) was extracted from the internal recording system of the Norwegian Veterinary Institute.
Isolates for which municipality information could be obtained were further included in the analyses of possible relationships between human population density and occurrence of QREC. Some of the production animals had been sampled at slaughterhouses and for some samples the exact knowledge of the production site was missing. We chose to use the municipality of the slaughterhouses as the geographical localization since the production animals in Norway are mainly slaughtered in one of the slaughterhouses closely located to the production site. Isolates from two wild birds, two layers, two sheep, one pig, one turkey, and all the isolates from both horses and dogs were excluded due to either lack of information, anonymized samples (horses) or only the localization of the veterinary clinic (dogs) was known.
The categorization of population density was performed as previously described (Mo et al., 2017) into the following categories: -Low population density (< five inhabitants per km 2 ) -Medium population density (five-200 inhabitants per km 2 ) -High population density (> 200 inhabitants per km 2 ) Data regarding the population density in 2015 (number of inhabitants per km 2 ) were derived from Statistics Norway (www.ssb.no, accessed 19.09.2017) .
Data management was performed in R version 3.4.2 (RCoreTeam, 2017) and in SAS SAS-PC system version 9.4 for Windows (SAS Institute inc., Cary, NC, USA).
Isolates and susceptibility testing
In total, 4568 isolates of indicator E. coli from various healthy animal species were included in this study (Table 1 ). Of these, information about municipality could be obtained for 4050 isolates. Sample material was either faecal, caecal or boot swabs. For broilers, all samples taken before 2014 were boot swabs, while after 2014 the samples were pooled caecal samples.
We did not have isolates from all species from all years due to the sample regimes in the NORM-VET surveillance programme, where only selected species are sampled each year. Due to this, only cattle, swine and broilers were analysed with regards to differences between years as they were sampled two, four and six times, respectively, over a ten year period. The isolation and identification of indicator E. coli in the NORM-VET programme follows standard guidelines used in general bacteriology. In short, putative E. coli colonies from faecal, caecal or boot swab samples are randomly selected on bromothymol-blue (in-house) or MacConkey agar (BD Biosciences, Le Pont de Claire, France), and species confirmation is done by indole, citrate and/or oxidase tests or by use of a matrix-assisted laser desorption/ionization time of flight apparatus (MALDI-TOF Microflex, Bruker Daltonik GmbH, Bremen, Germany). Minimum inhibitory concentration (MIC) values were determined by broth microdilution (VetMIC™, Dep. Of Antibiotics, National Veterinary Institute, Sweden, or SensiTitre ® , TREK Diagnostics, LTD.). All isolates of E. coli isolated between 2006 and 2013 were tested with VetMIC™, while isolates from 2014 to 2016 were tested with SensiTitre ® . MIC values of 0.016 mg/L from the VetMIC™ susceptibility testing system was grouped with the MIC value of 0.015 mg/L from the SensiTitre ® system, assuming that this does not affect the results as these MIC values are below the ECOFF. Isolates were classified as resistant if the MIC-values were above the ECOFF values 0.06 mg/L for ciprofloxacin and/or 16 mg/L for nalidixic acid, as defined by the European Committee on Antimicrobial Susceptibility Testing (EUCAST, www.eucast.org). Detailed methodology can be found in the NORM-VET reports (NORM/NORM- VET, 2006 VET, , 2007 VET, , 2008 VET, , 2009 VET, , 2010 VET, , 2011 VET, , 2012 VET, , 2013 VET, , 2014 VET, , 2015 VET, , 2016 , and also in Supplementary material. Quinolone resistant isolates that were MICtested by VetMIC™ (n = 31) were re-tested with the SensiTitre ® system to allow comparison with the ones previously tested on SensiTitre ® . Further, we classified the occurrence of resistance and resistance levels in accordance with guidelines from the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) (EFSA and ECDC, 2016).
Statistical analysis
The total occurrence of QREC across all species, per species, and per year during the ten year period was calculated. To assess differences in QREC occurrences between species, different human population density areas, and each year, chi squared tests were used. First, each species was compared to each other. Species with statistically significant differences in QREC occurrence were pooled and tested against the rest of the species as a group. The occurrence of QREC in relation to human population density was assessed by chi squared tests. Confidence intervals were calculated by using exact binomial test. All statistical analyses was performed in R version 3.4.2 (RCoreTeam, 2017). R script can be accessed at github.com/hkaspersen/vetmic2018.
All isolates (n = 4568) were included in the MIC-distribution for ciprofloxacin and nalidixic acid. Thereafter, only the isolates classified as resistant to either ciprofloxacin, nalidixic acid or both were included in the MIC-distribution for the substances where monitoring data from the total study period was available: ampicillin, tetracycline, chloramphenicol, sulfamethoxazole, trimethoprim, gentamicin and cefotaxime. Pearson correlation was used to assess possible associations between MIC-values for nalidixic acid and ciprofloxacin.
Trends in broilers from 2011 to 2016 were analysed by calculating the annual percent increase in QREC occurrence. 
Results
In total, 65 isolates (1.4%, 95% CI: [1.1-1.8]) were classified as resistant to quinolones. QREC was not detected in reindeer, sheep or horses. The occurrence was highest in broilers and wild birds ( Supplementary Fig. 1) , and significantly higher than all other animal species in this study (chi square test, p < 0.05; Table 1 ). The total occurrence of QREC was significantly higher in 2009, 2014 and 2016 compared to the most other years (chi square test, p < 0.05; Table 2 ). This is mostly due to the high proportion of samples from broilers in those years.
The occurrence of QREC over time in broilers ( Fig. 1 ) was significantly higher in 2009 and 2016 compared to 2006 and 2011 (chi square test, p < 0.05), with a mean QREC occurrence of 4.1%. The occurrence of QREC in broilers increased from 2011 to 2016, with an annual increase of 26.3%, excluding 2012 as only parent flocks were sampled that year. The occurrence of QREC in swine and cattle have been less than 1% during the whole study period ( Supplementary  Fig. 1) .
The MIC-distributions for ciprofloxacin and nalidixic acid from all isolates (Table 2) shows a difference between the MIC-distributions as a result of the use of two different systems for susceptibility testing. There is a positive correlation between the MIC-values of ciprofloxacin and nalidixic acid (Pearson correlation coefficient = 0.475). The occurrence of resistance to ampicillin (21.5%), tetracycline (27.7%), trimethoprim (16.9%) and sulfamethoxazole (16.9%) was detected in the 65 quinolone resistant isolates (Table 3) . Of these isolates, 21.5% were resistant to two different classes of antimicrobials, and 23.1% were resistant to three or more different classes. Two isolates had ciprofloxacin MIC-values above the ECOFF (MIC = 0.25 and 0.5 mg/L) and nalidixic acid MIC-values below the ECOFF (MIC = 4.0 and 8.0 mg/L; Fig. 2) , and multi-drug resistance to ampicillin, tetracycline and trimethoprim was detected in one of these isolates that originated from turkeys. Additionally, two isolates had ciprofloxacin MIC-values below the ECOFF (MIC = 0.015 and 0.06 mg/L) and nalidixic acid MIC-values above the ECOFF (MIC = 32 mg/L).
A possible association between the occurrence of QREC and human population density was only detected for layers (p = 0.011; Table 4 ).
Discussion
This study is to our knowledge the first study comparing the occurrence of QREC originating from production animals, companion animals, and wildlife. Here, we aggregated and analysed data gained through the NORM-VET surveillance programme in Norway for a ten year period (NORM/NORM- VET, 2006 VET, , 2007 VET, , 2008 VET, , 2009 VET, , 2010 VET, , 2011 VET, , 2012 VET, , 2013 VET, , 2014 VET, , 2015 VET, , 2016 to describe and compare the occurrence of QREC in different animal species, in relation to human population density and over time. Even though the sampling strategy, including sampled animal species, sample material and sampling location differed between the years, this study shows that the occurrence of QREC originating from healthy animals, including production-, wild-and Table 2 Minimum Inhibitory Concentration (MIC) distributions for nalidixic acid (NAL) and ciprofloxacin (CIP) for E. coli isolates (n = 4568) originating from all animal species included in the Norwegian monitoring programme for antimicrobial resistance in the years 2006-2016. The total number of isolates per year was 190 (2006), 458 (2007), 418 (2008), 333 (2009), 264 (2010), 400 (2011), 220 (2012), 474 (2013), 205 (2014), 532 (2015) , and 1074 (2016). MIC values above the epidemiological cut-off values included before 2014 have been retested in the present study with SensiTitre ® . The MIC value of 0.016 mg/L from the VetMIC™ system was grouped with the MIC value of 0.015 mg/L from the SensiTitre ® system.
Quinolone resistance
Distribution ( MIC values higher than the highest concentration tested are given as the lowest MIC value above the range. MIC values equal to or lower than the lowest concentration tested are given as the lowest concentration tested.
companion animals in Norway is low. In contrast, a similar study from Poland concerning only production animals reported a mean occurrence of 79.8% for broilers, 42.7% for layers, 61.0% for turkeys, 7.9% for pigs and 3.2% for cattle (Wasyl et al., 2013) . EFSA reports a mean QREC occurrence of 64% in broilers sampled in 2014 from 28 different European countries (EFSA and ECDC, 2016) , while Norway has an occurrence of 3.4%. Norway has a mean occurrence of QREC in broilers the last ten years at 6.3%, slightly lower than Sweden (SWEDRES/ SVARM, 2015) and Denmark (DANMAP, 2015) , with a mean occurrence of 11.0% and 9.5%, respectively. In 2015, Finland, Denmark and the Netherlands had similar occurrence of QREC in pigs as Norway, at 0.5%, 1.1%, 0.7% and 0.7%, respectively (EFSA and ECDC, 2017).
Our study indicates an interspecies variation in QREC occurrence, since there was a significantly higher occurrence of QREC in samples from broilers and wild birds than in other animals. This is consistent with the results of previous studies (Wasyl et al., 2013; Wasyl, 2014) and EFSA reports (EFSA and ECDC, 2010a , 2010b , 2016 , 2017 . The higher occurrence of QREC detected in broilers is also in accordance with the results obtained from the selective methodology used in NORM-VET since 2014. However, for further comparison of the interspecies variation detected by the traditional method, data from the same animal species and years need to be analysed simultaneously. In Sweden, a rapid increase in QREC occurrence from 5% to 15% from 2007 to 2010 was detected (SWEDRES/SVARM, 2015) . Similarly, an increasing trend is observed in Norway as well. This increasing trend, and the higher prevalence in broilers compared to other species is currently unexplained. To our knowledge, there has been no major changes in management during this time period. There was, however, a change in sample material from boot swab to pooled caecal samples, which could have influenced the results. However, an increase was also observed from 2014 and 2016, which do not support sampling procedure as an explanation for the observed increase. It has been suggested that QREC may originate from imported breeding birds (Börjesson et al., 2015) , and that vertical transmission of resistant bacterial clones to flocks downwards in the production pyramid can occur (EFSA and ECDC, 2016) . This might be an explanation for the occurrence of QREC in Norwegian broilers and other poultry since Norway imports eggs for the production of parent flocks from Sweden, and Sweden import grandparent flocks from breeding companies in the UK. Even if the occurrence of QREC is initially low, dissemination and spread within a poultry flock may be rapid due to high density of animals. Additionally, broiler feed have been implicated in the dissemination of QREC in broiler farms on Iceland (Thorsteinsdottir et al., 2010) and also in Portugal (da Costa et al., 2007) . In Norway, dry feed products for dogs, cattle and pigs have been screened for QREC without any QREC detection (NORM/NORM-VET, 2016). Broiler feed have not been examined and further investigations are needed to explore broiler feed as a source for QREC dissemination among broilers in Norway. However, multiple mechanisms may be responsible for the development of quinolone resistance. For example, bacterial stress factors have been shown to induce chromosomal mutations, which is typical for quinolone resistance (Qin et al., 2015) . Further surveillance data of QREC occurrence in broilers is of importance to follow the situation in Norway. The higher occurrence of QREC in broilers compared to turkeys have in other European countries been suggested to depend on an overall higher exposure to fluoroquinolones through the use of this antimicrobial (EFSA and ECDC, 2016) . To our knowledge, fluoroquinolones are not used in Norwegian broiler production (personal communication: Høy, T., The Norwegian Medicines Agency) and in almost negligible amounts in other animal species (NORM/NORM-VET, 2016). The difference in occurrence of QREC in the various animal species may indicate that the production environment may be an important factor. Broilers have the highest production density and also the highest QREC occurrence, while cattle have the lowest production density of the production animals and also one of the lowest QREC Fig. 1 . Prevalence from 2006 to 2016 of quinolone resistant E. coli from broilers included in the Norwegian monitoring programme for antimicrobial resistance in feed, food and animals. Confidence intervals (95%) are denoted as black lines above and within the bars. *Breeders.
Table 3
Minimum inhibitory concentration distributions for the quinolone resistant E. coli isolates (n = 65) for the antimicrobials AMP = ampicillin, TET = tetracycline, CHL = chloramphenicol, SMX = sulfamethoxazole, TMP = trimethoprim, GEN = gentamicin, and CTX = cefotaxime.
*Bold vertical lines denote epidemiological cut-off values for resistance. CI = confidence interval. White fields denote range of dilutions tested for each antimicrobial agent. MIC values higher than the highest concentration tested are given as the lowest MIC value above the range. MIC values equal to or lower than the lowest concentration tested are given as the lowest concentration tested.
occurrences. However, studies that link production density to the dissemination of antimicrobial resistance have to our knowledge not been performed but theoretical models show that the ability for an infectious agent to spread depends on the number of possible contacts (de Jong et al., 1995) .
No selection pressure for quinolone resistance is expected in wild animals, as quinolones are not naturally found in nature. However, QREC may be disseminated to the environment from human and animal sources through wastewater, manure etc. In the present study, isolates from wild birds and dogs were found to have the highest MIC-values for ciprofloxacin (> 8 μg/ml, data not shown). Such a high MIC-value suggests multiple resistance mechanisms (Vila et al., 1994; Machuca et al., 2014) . It has previously been suggested that wild birds may be reservoirs for quinolone resistance (Oh et al., 2016) , and due to their freedom of movement may disseminate this resistance to other countries. Similar to wild birds, dogs may be exposed to sources of QREC in the environment in addition to being in close contact with humans. However, wild birds and dogs were only sampled in 2016, and 2008 and 2013, respectively, and care should therefore be taken when interpreting these results.
We hypothesized that there might be an influence of human activity on the occurrence of QREC. Earlier reports have suggested a link between human population density and the occurrence of antimicrobial resistance (Bruinsma, 2003; Mo et al., 2017) . We therefore compared the occurrence of QREC in relation to human population density categorized in low, medium and high density areas. No association between the occurrence of QREC and human population density was detected, except for layers, where no QREC was identified in low and medium density categories and only one QREC isolate in the high density category. Even if this is a significant result, care should be taken when interpreting these results due to the small sample size. Human population density data from 2015 was used to identify the population categories for each municipality. Only the data from 2015 was used, as the demographic structure in Norway have been relatively stable the last ten years. The population categories for each municipality would therefore most likely stay the same if categorised for each year. In a recent report (Mo et al., 2017) , where a selective screening of QREC from red foxes was performed, there was a higher occurrence in the high density category when compared to less populated areas. Production animals in Norway is mostly kept in close premises with little to no contact with human waste, sewage etc. that might contain resistant bacteria, therefore the influence from these sources is probably less for production animals than for other animals. Fig. 2 . The number of minimum inhibitory concentration (MIC) value combinations for ciprofloxacin (CIP) and nalidixic acid (NAL) for the quinolone resistant E. coli isolates in this study (n = 65). Vertical and horizontal lines indicate epidemiological cut off values for the respective antimicrobial compound. The MIC value of 0.016 mg/L from the VetMIC™ susceptibility testing system was grouped with the MIC value of 0.015 mg/ L from the SensiTitre ® system.
Table 4
Occurrence of quinolone resistant E. coli from different animal species sampled within three population densities. Resistance was defined by the epidemiological cut-off value for ciprofloxacin and nalidixic acid, as defined by EUCAST. Evaluating the MIC-values for ciprofloxacin and nalidixic acid may give an indication regarding the underlying resistance mechanism in a given isolate where a decreased susceptibility to ciprofloxacin but increased susceptibility to nalidixic acid is indicative of plasmid mediated quinolone resistance (PMQR) and the presence of qnr-genes (Hooper and Jacoby, 2015) . In this study, two E. coli isolates had increased susceptibility for nalidixic acid and decreased susceptibility for ciprofloxacin, indicating the presence of PMQR. These isolates were obtained from one wild bird and a turkey. Furthermore, the multi-drug resistance identified in the turkey isolate further supports this hypothesis. However, the presence of PMQR and the specific resistance genes needs to be confirmed by whole-genome sequencing.
Conclusion
The results indicate a low occurrence of QREC in various animal species in Norway. Fluoroquinolones are not used prophylactically in Norway, and almost negligent amounts have been used for treatment of animals. The source of this observed resistance is therefore unknown. However, there is a significant difference in the occurrence of QREC between the animal species, which might indicate that other factors than fluoroquinolone use may play a role in the occurrence of QREC. These factors are currently unknown, and further research is needed to investigate possible explanations.
